341 related articles for article (PubMed ID: 30396385)
1. Analgesic effects of the novel α₂δ ligand mirogabalin in a rat model of spinal cord injury.
Domon Y; Kitano Y; Makino M
Pharmazie; 2018 Nov; 73(11):659-661. PubMed ID: 30396385
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic effects of the novel α
Murasawa H; Kobayashi H; Saeki K; Kitano Y
Psychopharmacology (Berl); 2020 Jan; 237(1):189-197. PubMed ID: 31515584
[TBL] [Abstract][Full Text] [Related]
3. Analgesic effects of mirogabalin, a novel ligand for α
Saeki K; Yasuda SI; Kato M; Kano M; Domon Y; Arakawa N; Kitano Y
Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):723-728. PubMed ID: 30770951
[TBL] [Abstract][Full Text] [Related]
4. Effects of mirogabalin, a novel ligand for the α₂δ subunit of voltage-gated calcium channels, on N-type calcium channel currents of rat dorsal root ganglion culture neurons.
Kitano Y; Wakimoto S; Tamura S; Kubota K; Domon Y; Arakawa N; Saito M; Sava B; Buisson B
Pharmazie; 2019 Mar; 74(3):147-149. PubMed ID: 30961679
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytic-like effects of mirogabalin, a novel ligand for α
Murasawa H; Kobayashi H; Yasuda SI; Saeki K; Domon Y; Arakawa N; Kubota K; Kitano Y
Pharmacol Rep; 2020 Jun; 72(3):571-579. PubMed ID: 32270470
[TBL] [Abstract][Full Text] [Related]
6. Binding Characteristics and Analgesic Effects of Mirogabalin, a Novel Ligand for the
Domon Y; Arakawa N; Inoue T; Matsuda F; Takahashi M; Yamamura N; Kai K; Kitano Y
J Pharmacol Exp Ther; 2018 Jun; 365(3):573-582. PubMed ID: 29563324
[TBL] [Abstract][Full Text] [Related]
7. Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states.
Boroujerdi A; Zeng J; Sharp K; Kim D; Steward O; Luo DZ
Pain; 2011 Mar; 152(3):649-655. PubMed ID: 21239111
[TBL] [Abstract][Full Text] [Related]
8. Mirogabalin activates the descending noradrenergic system by binding to the α
Oyama M; Watanabe S; Iwai T; Tanabe M
J Pharmacol Sci; 2021 May; 146(1):33-39. PubMed ID: 33858653
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological, pharmacodynamics, and clinical profile of mirogabalin besylate (Tarlige
Kitano Y; Kai K; Yamamura N; Yoshiba S; Kuroha M
Nihon Yakurigaku Zasshi; 2019; 154(6):352-361. PubMed ID: 31787689
[TBL] [Abstract][Full Text] [Related]
10. Chronic administration of [Pyr
Hajimashhadi Z; Aboutaleb N; Nasirinezhad F
Neuropeptides; 2017 Feb; 61():15-22. PubMed ID: 27686494
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation.
Geng SJ; Liao FF; Dang WH; Ding X; Liu XD; Cai J; Han JS; Wan Y; Xing GG
Exp Neurol; 2010 Apr; 222(2):256-66. PubMed ID: 20079352
[TBL] [Abstract][Full Text] [Related]
12. Administration of ONO-2506 suppresses neuropathic pain after spinal cord injury by inhibition of astrocytic activation.
Ishiguro H; Kaito T; Hashimoto K; Kushioka J; Okada R; Tsukazaki H; Kodama J; Bal Z; Ukon Y; Takenaka S; Makino T; Sakai Y; Yoshikawa H
Spine J; 2019 Aug; 19(8):1434-1442. PubMed ID: 30974239
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of calcium channel alpha-2-delta-1 subunit in dorsal horn contributes to spinal cord injury-induced tactile allodynia.
Kusuyama K; Tachibana T; Yamanaka H; Okubo M; Yoshiya S; Noguchi K
Spine J; 2018 Jun; 18(6):1062-1069. PubMed ID: 29355786
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the spinal astrocytic JNK/MCP-1 pathway activation correlates with the analgesic effects of tanshinone IIA sulfonate in neuropathic pain.
Tang J; Zhu C; Li ZH; Liu XY; Sun SK; Zhang T; Luo ZJ; Zhang H; Li WY
J Neuroinflammation; 2015 Mar; 12():57. PubMed ID: 25889689
[TBL] [Abstract][Full Text] [Related]
15. Spinal 5-HT3 receptor mediates nociceptive effect on central neuropathic pain; possible therapeutic role for tropisetron.
Nasirinezhad F; Hosseini M; Karami Z; Yousefifard M; Janzadeh A
J Spinal Cord Med; 2016; 39(2):212-9. PubMed ID: 26338446
[TBL] [Abstract][Full Text] [Related]
16. Viral vectors encoding endomorphins and serine histogranin attenuate neuropathic pain symptoms after spinal cord injury in rats.
Nasirinezhad F; Gajavelli S; Priddy B; Jergova S; Zadina J; Sagen J
Mol Pain; 2015 Jan; 11():2. PubMed ID: 25563474
[TBL] [Abstract][Full Text] [Related]
17. Pannexin 1: a novel participant in neuropathic pain signaling in the rat spinal cord.
Bravo D; Ibarra P; Retamal J; Pelissier T; Laurido C; Hernandez A; Constandil L
Pain; 2014 Oct; 155(10):2108-15. PubMed ID: 25102401
[TBL] [Abstract][Full Text] [Related]
18. Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain.
Tzschentke TM; Linz K; Frosch S; Christoph T
Pain Pract; 2017 Nov; 17(8):1032-1041. PubMed ID: 28112482
[TBL] [Abstract][Full Text] [Related]
19. The Novel Gabapentinoid Mirogabalin Prevents Upregulation of α2δ-1 Subunit of Voltage-Gated Calcium Channels in Spinal Dorsal Horn in a Rat Model of Spinal Nerve Ligation.
Domon Y; Kobayashi N; Kubota K; Kitano Y; Ueki H; Shimojo Y; Ishikawa K; Ofune Y
Drug Res (Stuttg); 2023 Jan; 73(1):54-60. PubMed ID: 36216339
[TBL] [Abstract][Full Text] [Related]
20. The novel analgesic compound OT-7100 (5-n-butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo[1,5-a]pyrimid ine) attenuates mechanical nociceptive responses in animal models of acute and peripheral neuropathic hyperalgesia.
Yasuda T; Iwamoto T; Ohara M; Sato S; Kohri H; Noguchi K; Senba E
Jpn J Pharmacol; 1999 Jan; 79(1):65-73. PubMed ID: 10082319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
